PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-54.21%
Both yoy net incomes decline, with CSIQ at -68.38%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-98.03%
Negative yoy D&A while CSIQ is 4.11%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-79.51%
Negative yoy deferred tax while CSIQ stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-35.29%
Negative yoy SBC while CSIQ is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
843.36%
Well above CSIQ's 114.32% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
216.47%
AR growth of 216.47% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
281.62%
Inventory growth of 281.62% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-2710.57%
Negative yoy AP while CSIQ is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-100.22%
Negative yoy usage while CSIQ is 114.32%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
1908.77%
Some yoy increase while CSIQ is negative at -95.50%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-5.06%
Both yoy CFO lines are negative, with CSIQ at -45.47%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
7.77%
Some CapEx rise while CSIQ is negative at -20.48%. John Neff would see competitor possibly building capacity while we hold back expansions.
89.85%
Acquisition growth of 89.85% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We reduce yoy sales while CSIQ is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
91.97%
We have some outflow growth while CSIQ is negative at -457.46%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
71.97%
We have mild expansions while CSIQ is negative at -43.70%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-100.07%
We cut debt repayment yoy while CSIQ is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
43.91%
Buyback growth of 43.91% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.